Get my own profile
Public access
View all29 articles
0 articles*
available
not available
Based on funding mandates
Co-authors
Laura Perez-BenitoSenior Scientist Computational Chemistry JanssenVerified email at its.jnj.com
Herman van VlijmenHead, Computational ChemistryVerified email at its.jnj.com
David MobleyProfessor, University of California, IrvineVerified email at uci.edu
David HahnJanssen RNDVerified email at its.jnj.com
vytautas gapsysSenior Scientist at Janssen (Johnson & Johnson). Previously, project leader at Max Planck InstituteVerified email at gwdg.de
Andreas BenderProfessor for Molecular Informatics in CambridgeVerified email at cam.ac.uk
Peter BuijnstersPrincipal Scientist, The Janssen Pharmaceutical Companies of Johnson & JohnsonVerified email at its.jnj.com
Bert L. de GrootMax Planck Institute for multidisciplinary sciencesVerified email at gwdg.de
Dimitris K AgrafiotisVice President, PfizerVerified email at generatebiomedicines.com
John D. ChoderaMemorial Sloan-Kettering Cancer CenterVerified email at mskcc.org
Thomas SteinbrecherSchrödinger GmbHVerified email at schrodinger.com
Antonia S J S MeyChancellor's Fellow at the University of EdinburghVerified email at ed.ac.uk
Henrik KeränenJanssen pharmaceuticaVerified email at its.jnj.com
Xavier LucasSenior scientist in computational drug design at Monte Rosa Therapeutics, BaselVerified email at monterosatx.com
Jeffrey R WagnerSoftware Scientist, Open Force Field InitiativeVerified email at ucsd.edu
Julien MichelProfessor of Biomolecular Simulation, University of EdinburghVerified email at ed.ac.uk
Adrian MulhollandProfessor of Chemistry, University of BristolVerified email at bristol.ac.uk
Caitlin C. BannanOpenEye ScientificVerified email at eyesopen.com
Yudong QiuPostdoctoral Researcher at UC DavisVerified email at ucdavis.edu
Michael K GilsonUniversity of California San DiegoVerified email at health.ucsd.edu
Follow
Gary Tresadern
Computational chemistry, Janssen R&D, Pharmaceutical companies of Johnson and Johnson
Verified email at its.jnj.com